Two lawmakers who co-chaired a major commission on cybersecurity are urging HHS to protect the health care industry from cyber threats through increasing information sharing, and to provide an explanation on current mechanisms in place.
GET 30 DAYS FREE
Sign up for 30 days of no-obligation access for all the essential news during this critical time -- you'll be able to choose one of our online services as part of your trial: Inside CMS, FDA Week, Health Exchange Alert, Inside Drug Pricing or Inside TeleHealth.
Home
Top Story
IRA Heads To President; CMS Prepares For Historic Drug Price Negotiation
The House Friday (Aug. 12) teed up Democrats’ long-sought drug-pricing reforms for President Joe Biden’s signature, after which CMS will start putting the pieces together to negotiate Medicare drug prices.
Related Document: Reactions To House Passage Of Reconciliation Bill
ARP Extension Heads To Biden’s Desk Days Before QHP Filings Due
Comprehensive Abortion Coverage
WH Eyes Medicaid 1115 Waivers For Interstate Abortion Within Hyde Limits
The White House is considering using Medicaid 1115 waivers to establish federal support for people living in abortion-hostile states who seek access to abortion and other reproductive care elsewhere, which a CMS official told Inside Health Policy could expand access to care for Medicaid enrollees whose pregnancies are the result of rape or incest, or whose lives are at risk.
GOP Hones Abortion Language; IN Enacts Strict Ban; MN Court Hears Emergency Contraception Case
Latest Pandemic News
As CDC Drops Some COVID Precautions, Jha Points To Future Of Next-Gen Vaccines
Repeated booster shots and next-generation vaccines that protect against new variants will be the best way to decrease COVID-19 cases, White House COVID-19 response coordinator Ashish Jha said as the Centers for Disease Control and Prevention released new guidelines that loosen some recommendations for preventing contagion while suggesting congregate settings like long-term care facilities might want to continue testing asymptomatic individuals.
FDA Recommends Repeated COVID-19 Testing To Avoid False Negatives
Nursing Homes Ask HHS To Extend PHE Beyond October
Latest News
House lawmakers from both parties are holding discussions with key senators in a bid to create momentum for the upper chamber to pass in September broad bipartisan mental health legislation that cleared the House in June.
The American Clinical Laboratory Association launched a “Stop Lab Cuts” campaign aimed at heading off Medicare laboratory payment cuts by pressing lawmakers to pass lab pay system reform legislation by the end of the year.
More than three out of four community pharmacists are swamped by a staffing shortage they say is worsened by inflation and causing them to struggle to maintain their businesses, according to a new survey from the National Community Pharmacists Association.
A European data law that went into effect in 2018 has hindered FDA’s ability to do in-person inspections and remote regulatory assessments and to review data remotely during the pandemic, and the agency is concerned the law will have even broader consequences for clinical trial data sharing, adverse event reporting and medical product applications, Heather Messick, regulatory counsel for FDA’s drug center, wrote Tuesday (Aug. 9).
More than 100 public health, tobacco control and medical organizations from around the world are calling on a United Nations human rights panel to recommend the United States remove menthol from all tobacco products without loopholes, and ban tobacco advertising targeted at racial minority groups.
The House Rules Committee late Wednesday cleared Democrats’ reconciliation package for a floor vote Friday (Aug. 12) with three hours of debate and no points of order -- the last step to bringing the party’s signature health care, climate change and deficit reduction package to President Joe Biden’s desk.
Focus On Monkeypox
CDC Conducting Studies To Better Understand The Spread Of Monkeypox
The Centers for Disease Control and Prevention is launching a series of observational studies to better understand how monkeypox spreads in congregate settings and how it affects people who receive post-exposure prophylaxis (PEP++) after coming into contact with the virus, the White House revealed Thursday (Aug. 11) in a fact sheet detailing the Biden administration’s monkeypox research priorities.
CDC Expanding COVID Wastewater Surveillance Sites To Track Monkeypox
NIH Will Conduct Clinical Trials Of TPOXX For Monkeypox In The U.S., DRC
BARDA Makes $26 Million Purchase of Monkeypox Drug Tecovirimat
FDA Clears Dose-Sparing Method For Monkeypox Vax To Quintuple Supply
Republicans Demand Faster Monkeypox Response, But No Mandates
FDA Defers Blood Donor Screening Recs For Monkeypox, For Now
FDA Eyes New Administration Method For Monkeypox Vax To Boost Supply
Covering the hottest new health policy debate in Washington -- in-depth reporting on the surging efforts to tackle social, racial and economic barriers to equitable health care.
© 2002-2022. Inside Washington Publishers | Contact Us
About This Site
InsideHealthPolicy.com is a subscription-based news service. Access requires a subscription to one or more of our three areas of coverage (listed below), each of which includes both online and print components.
New: Health Exchange Alert - Daily news and analysis on the hottest issue in health care reform – federal and state requirements for the creation of health insurance exchanges.
Inside CMS - Covering Medicare and Medicaid from the inside out.
FDA Week - Exclusive reporting on the Food and Drug Administration's regulation of drugs, devices, food safety and related areas.
Sign up for one month of free, no-obligation access to InsideHealthPolicy.com.